|
GTF2A2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.74571509762245E-13 |
| Normal-vs-Stage2 |
2.412800E-04 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
2.15879536469288E-11 |
| Stage1-vs-Stage2 |
2.633200E-01 |
| Stage1-vs-Stage3 |
1.229820E-02 |
| Stage1-vs-Stage4 |
9.669400E-01 |
| Stage2-vs-Stage3 |
2.979700E-02 |
| Stage2-vs-Stage4 |
2.827200E-01 |
| Stage3-vs-Stage4 |
5.616000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
1.11309994554887E-09 |
| Normal-vs-Asian |
3.039100E-04 |
| Caucasian-vs-AfricanAmerican |
1.972780E-01 |
| Caucasian-vs-Asian |
3.653000E-01 |
| AfricanAmerican-vs-Asian |
1.058830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
6.71351862990832E-13 |
| Male-vs-Female |
7.755400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.08230141199806E-11 |
| Normal-vs-Age(41-60Yrs) |
1.65234492754962E-12 |
| Normal-vs-Age(61-80Yrs) |
3.41948691584548E-14 |
| Normal-vs-Age(81-100Yrs) |
4.581200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.700400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.333600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.998580E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.976000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.457450E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.445020E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.43670000005447E-06 |
| Normal-vs-Grade 2 |
4.10727007960077E-12 |
| Normal-vs-Grade 3 |
1.63080660087189E-12 |
| Normal-vs-Grade 4 |
1.70463643200947E-12 |
| Grade 1-vs-Grade 2 |
7.420600E-01 |
| Grade 1-vs-Grade 3 |
2.488000E-01 |
| Grade 1-vs-Grade 4 |
2.230000E-01 |
| Grade 2-vs-Grade 3 |
3.628300E-02 |
| Grade 2-vs-Grade 4 |
5.311900E-02 |
| Grade 3-vs-Grade 4 |
6.545000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.63213886850144E-12 |
| Normal-vs-ccB subtype |
1.62458935193399E-12 |
| ccA subtype-vs-ccB subtype |
2.643000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.64357416565508E-12 |
| Normal-vs-N1 |
4.55100000018582E-07 |
| N0-vs-N1 |
8.349400E-01 |
|
|
